Structure Therapeutics Inc.
GPCR
$32.12
-$2.45-7.09%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -65.71M | -61.66M | -46.83M | -36.48M | -33.98M |
| Total Depreciation and Amortization | 379.00K | 291.00K | 274.00K | 266.00K | 276.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.83M | 3.73M | 1.13M | 280.00K | 302.00K |
| Change in Net Operating Assets | 9.51M | 3.08M | -6.80M | -534.00K | 13.70M |
| Cash from Operations | -51.00M | -54.56M | -52.23M | -36.47M | -19.70M |
| Capital Expenditure | -1.57M | -232.00K | -314.00K | -16.00K | -685.00K |
| Sale of Property, Plant, and Equipment | 5.16M | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -52.91M | 49.17M | 34.35M | 33.25M | -188.36M |
| Cash from Investing | -49.32M | 48.94M | 34.03M | 33.23M | -189.04M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 57.44M | 517.00K | 965.00K | 615.00K | 397.00K |
| Repurchase of Common Stock | -462.00K | 0.00 | -156.00K | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -770.00K | -- | -- | 0.00 | -1.15M |
| Cash from Financing | 56.20M | 517.00K | 809.00K | 615.00K | -757.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -44.11M | -5.10M | -17.39M | -2.62M | -209.50M |